Role of phorbol ester localization in determining protein kinase C or RasGRP3 translocation: Real-time analysis using fluorescent ligands and proteins

Molecular Cancer Therapeutics

Volumn 4, Issue 1, 2005, Pages 141-150

  Braun, Derek C ^a,b   Cao, Yeyu ^d   Wang, Shaomeng ^d   Garfield, Susan H ^c   Hur, Gang Min ^b   Blumberg, Peter M ^b  

^a GALLAUDET UNIVERSITY   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCENT DYE; GREEN FLUORESCENT PROTEIN; GUANINE NUCLEOTIDE EXCHANGE FACTOR; GUANINE NUCLEOTIDE EXCHANGE FACTOR 3; PHORBOL 13 ACETATE 12 MYRISTATE; PHORBOL DIBUTYRATE; PHORBOL ESTER DERIVATIVE; PROTEIN KINASE C; PROTEIN KINASE C ALPHA; PROTEIN KINASE C DELTA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CELLULAR DISTRIBUTION; CHO CELL; CONTROLLED STUDY; INTRACELLULAR MEMBRANE; LIGAND BINDING; LIPOPHILICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT;

ANIMALS; BIOLOGICAL TRANSPORT; CHO CELLS; CRICETINAE; FLUORESCENT DYES; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; KINETICS; LIGANDS; MICROSCOPY, CONFOCAL; PHORBOL 12,13-DIBUTYRATE; PROTEIN KINASE C; PROTEIN TRANSPORT; RECOMBINANT FUSION PROTEINS; TETRADECANOYLPHORBOL ACETATE;

EID: 13944257428     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Newton AC. Protein kinase C: structure, function, and regulation. J Biol Chem 1995;270:28495-8.
2. Mochly-Rosen D, Kauvar LM. Pharmacological regulation of network kinetics by protein kinase C localization. Semin Immunol 2000;12:55-61.
3. Kazanietz MG. Eyes wide shut: protein kinase C isozymes are not the only receptors for the phorbol ester tumor promoters. Mol Carcinog 2000;28:5-11.
4. Teixeira C, Stang SL, Zheng Y, Beswick NS, Stone JC. Integration of DAG signaling systems mediated by PKC-dependent phosphorylation of RasGRP3. Blood 2003;102:1414-20.
5. Lorenzo PS, Beheshti M, Pettit GR, Stone JC, Blumberg PM. The guanine nucleotide exchange factor RasGRP is a high-affinity target for diacylglycerol and phorbol esters. Mol Pharmacol 2000; 57:840-6.
6. Lorenzo PS, Kung JW, Bottorff DA, Garfield SH, Stone JC, Blumberg PM. Phorbol esters modulate the Ras exchange factor RasGRP3. Cancer Res 2001;61:943-9.
7. Hurley JH, Newton AC, Parker PJ, Blumberg PM, Nishizuka Y. Taxonomy and function of C1 protein kinase C homology domains. Protein Sci 1997;6:477-80.
8. Newton AC. Protein kinase C. Seeing two domains. Curr Biol 1995;5:973-6.
9. Mackay HJ, Twelves CJ. Protein kinase C: a target for anticancer drugs? Endocr Relat Cancer 2003;10:389-96.
10. Brodie C, Blumberg PM. Regulation of cell apoptosis by protein kinase C δ. Apoptosis 2003;8:19-27.
11. Tonetti DA, Chisamore MJ, Grdina W, Schurz H, Jordan VC. Stable transfection of protein kinase C α cDNA in hormone-dependent breast cancer cell lines. Br J Cancer 2000;83:782-91.
12. Krasagakis K, Lindschau C, Fimmel S, et al. Proliferation of human melanoma cells is under tight control of protein kinase C α. J Cell Physiol 2004;199:381-7.
13. O'Brian CA, Ward NE, Stewart JR, Chu F. Prospects for targeting protein kinase C isozymes in the therapy of drug-resistant cancer - an evolving story. Cancer Metastasis Rev 2001;20:95-100.
14. Clamp A, Jayson GC. The clinical development of the bryostatins. Anticancer Drugs 2002;13:673-83.
15. Strair RK, Scheer D, Goodell L, et al. Administration of a phorbol ester to patients with hematological malignancies: preliminary results from a phase I clinical trial of 12-O tetradecanoylphorbol-13-acetate. Clin Cancer Res 2002;8:2512-8.
16. Ogbourne SM, Suhrbier A, Jones B, et al. Antitumor activity of 3-ingenyl angelate: plasma membrane and mitochondrial disruption and necrotic cell death. Cancer Res 2004;64:2833-9.
17. Roychowdhury D, Lahn M. Antisense therapy directed to protein kinase C-α (Affinitak, LY900003/ISIS 3521): potential role in breast cancer. Semin Oncol 2003;30:30-3.
18. Hanauske AR, Sundell K, Lahn M. The role of protein kinase C-α (PKC-α) in cancer and its modulation by the novel PKC-α-specific inhibitor aprinocarsen. Curr Pharm Des 2004; 10:1923-36.
19. Mandlekar S, Kong AN. Mechanisms of tamoxifen-induced apoptosis. Apoptosis 2001;6:469-77.
20. Roaten JB, Kazanietz MG, Caloca MJ, et al. Interaction of the novel anthracycline antitumor agent N-benzyladriamycin-14-valerate with the C1-regulatory domain of protein kinase C: structural requirements, isoform specificity, and correlation with drug cytotoxicity. Mol Cancer Ther 2002;1:483-92.
21. Ishii H, Koya D, King GL. Protein kinase C activation and its role in the development of vascular complications in diabetes mellitus. J Mol Med 1998;76:21-31.
22. Gustafson KR, Cardellina JH, McMahon JB, et al. A nonpromoting phorbol from the Samoan medicinal plant Homalanthus nutans inhibits cell killing by HIV-1. J Med Chem 1992;35:1978-86.
23. Bocklandt S, Blumberg PM, Hamer DH. Activation of latent HIV-1 expression by the potent anti-tumor promoter 12-deoxyphorbol 13-phenylacetate. Antiviral Res 2003;59:89-98.
24. Oancea E, Meyer T. Protein kinase C as a molecular machine for decoding calcium and diacylglycerol signals. Cell 1998;95:307-18.
25. Wang QJ, Bhattacharyya D, Garfield S, Nacro K, Marquez VE, Blumberg PM. Differential localization of protein kinase C δ by phorbol esters and related compounds using a fusion protein with green fluorescent protein. J Biol Chem 1999;274:37233-9.
26. Wang QJ, Fang TW, Fenick D, et al. The lipophilicity of phorbol esters as a critical factor in determining the pattern of translocation of protein kinase C δ fused to green fluorescent protein. J Biol Chem 2000;275:12136-46.
27. Shirai Y, Sakai N, Saito N. Subspecies-specific targeting mechanism of protein kinase C. Jpn J Pharmacol 1998;78:411-7.
28. Marquez VE, Blumberg PM. Synthetic diacylglycerols (DAG) and DAG-lactones as activators of protein kinase C (PK-C). Acc Chem Res 2003;36:434-43.
29. Sambrook J, Russell DW. Molecular cloning. 3rd ed. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory; 2001. 3 vols.
30. 3H]Phorbol 12,13-dibutyrate binding assay for protein kinase C and related proteins. Methods Mol Biol 2003;233:129-56.
31. Kazanietz MG, Krausz KW, Blumberg PM. Differential irreversible insertion of protein kinase C into phospholipid vesicles by phorbol esters and related activators. J Biol Chem 1992;267:20878-86.
32. Meylan WM, Howard PH. Atom/fragment contribution method for estimating octanol-water partition coefficients. J Pharm Sci 1995;84: 83-92.
33. Slater SJ, Ho C, Stubbs CD. The use of fluorescent phorbol esters in studies of protein kinase C-membrane interactions. Chem Phys Lipids 2002;116:75-91.
34. Karolin J, Johannson LB-A, Strandberg L, Ny T. Fluorescence and absorption spectroscopic properties of dypyrrometheneboron difluoride (BODIPY) derivatives in liquids, lipid membranes, and proteins. J Am Chem Soc 1994;116:7801-6.
35. Jacobson K, Wenner CE, Kemp G, Papahadjopoulos D. Surface properties of phorbol esters and their interaction with lipid monolayers and bilayers. Cancer Res 1975;35:2991-5.
36. 3H]phorbol 12,13-dibutyrate binding. Cancer Res 1985;45:19-24.
37. Murphy TV, Prountzos C, Kotsonis P, Iannazzo L, Majewski H. Structural determinants of phorbol ester binding in synaptosomes: pharmacokinetics and pharmacodynamics. Eur J Pharmacol 1999;381: 77-84.
38. Szallasi Z, Smith CB, Blumberg PM. Dissociation of phorbol esters leads to immediate redistribution to the cytosol of protein kinases C α and C δ in mouse keratinocytes. J Biol Chem 1994;269:27159-62.
39. Tran PL, Deugnier MA. Intracellular localization of 12-O 3-N-dansylamino TPA in C3H/10T1/2 mouse cell line. Carcinogenesis 1985;6:433-9.
40. Horowitz AD, Greenebaum E, Weinstein IB. Identification of receptors for phorbol ester tumor promoters in intact mammalian cells and of an inhibitor of receptor binding in biologic fluids. Proc Natl Acad Sci U S A 1981;78:2315-9.
41. Horowitz AD, Greenebaum E, Nicolaides M, Woodward K, Weinstein IB. Inhibition of phorbol ester-receptor binding by a factor from human serum. Mol Cell Biol 1982;2:545-53.
42. Shoyab M, Todaro GJ. Partial purification and characterization of a binding protein for biologically active phorbol and ingenol esters from murine sera. J Biol Chem 1982;257:439-45.
43. Walker SD, Murray NR, Burns DJ, Fields AP. Protein kinase C chimeras: catalytic domains of α and β II protein kinase C contain determinants for isotype-specific function. Proc Natl Acad Sci U S A 1995;92:9156-60.
44. Schechtman D, Mochly-Rosen D. Adaptor proteins in protein kinase C-mediated signal transduction. Oncogene 2001;20:6339-47.